ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 914,65
-0,88%
Dow Jones
38 225,66
0,85%
DAX
17 896,50
-0,14%
Brent Oil
83,72
0,11%
Bitcoin
58 841,70
-0,47%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Evoke Pharma Inc (EVOK)

  7. Evoke Pharma Inc (EVOK) Actualités

EVOK Evoke Pharma Inc

0,4577
-0,0223 (-4,65%)
02 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Evoke Pharma Inc EVOK NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,0223 -4,65% 0,4577 22:30:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,453 0,4104 0,55 0,4577 0,48
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
17/4/202414:30GLOBEEvoke Pharma to Host Virtual Key Opinion Leader (KOL)..
21/3/202421:15GLOBEEvoke Pharma Announces Senior Leadership Transition with..
14/3/202421:05GLOBEEvoke Pharma Reports Fourth Quarter and Full Year 2023..
07/3/202422:10GLOBEEvoke Pharma to Report Fourth Quarter and Full Year 2023..
23/2/202422:15EDGAR2Form 8-K - Current report
20/2/202422:38EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202415:00EDGAR2Form 8-K - Current report
14/2/202413:30GLOBEEvoke Pharma Announces Closing of $7.5 Million Public..
09/2/202423:15EDGAR2Form 8-K - Current report
09/2/202423:14EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
09/2/202413:30GLOBEEvoke Pharma Announces Pricing of Underwritten Public..
09/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
08/2/202412:50EDGAR2Form S-1/A - General form for registration of securities..
11/1/202403:38EDGAR2Form S-1/A - General form for registration of securities..
04/1/202422:30EDGAR2Form S-1/A - General form for registration of securities..
19/12/202314:30EDGAR2Form S-1/A - General form for registration of securities..
15/12/202322:30EDGAR2Form S-1/A - General form for registration of securities..
29/11/202315:00EDGAR2Form 8-K - Current report
27/11/202322:30EDGAR2Form 8-K - Current report
27/11/202314:30GLOBEEvoke Pharma Announces FDA Orange Book Listing of New GIMOTI..
22/11/202322:15EDGAR2Form 8-K - Current report
14/11/202314:30GLOBEUnited States Patent and Trademark Office (USPTO) Grants..
09/11/202322:30EDGAR2Form S-1 - General form for registration of securities under..
09/11/202315:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202315:00EDGAR2Form 8-K - Current report
09/11/202314:30GLOBEEvoke Pharma Reports Third Quarter 2023 Financial Results
01/11/202313:30EDGAR2Form 8-K - Current report
31/10/202313:30GLOBEEvoke Pharma & EVERSANA Unveil Cost Savings Real-World Data..
18/10/202314:30GLOBEEvoke Pharma’s Abstract Entitled “Superiority of Nasal Spray..
12/10/202322:30EDGAR2Form 8-K - Current report
14/9/202314:30GLOBEEvoke Pharma Receives Notice of Allowance from USPTO for..
11/8/202315:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/8/202315:03EDGAR2Form 8-K - Current report
10/8/202315:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202314:30GLOBEEvoke Pharma Reports Second Quarter 2023 Financial Results
07/8/202314:30GLOBEEvoke Pharma and EVERSANA Announce Abstract Acceptance at..
25/7/202314:30GLOBEEvoke Pharma and EVERSANA Announce Abstract Selection for..
21/7/202315:00EDGAR2Form 8-K - Current report
14/6/202314:30GLOBEEvoke Pharma to Host First Key Opinion Leader Webinar on..
15/5/202322:05GLOBEEvoke Pharma Reports First Quarter 2023 Financial Results
09/5/202313:00GLOBEReal-World Data Presented by Evoke Pharma and EVERSANA at..
04/5/202314:30GLOBEEvoke Pharma’s Real-World Healthcare Utilization Data..

Dernières Valeurs Consultées

NASDAQ
EVOK
Evoke Pharma
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés